IFNG and acute myeloid leukemia: In a phase I pilot study in patients with relapsed AML and MDS, IFN-γ followed by donor lymphocyte infusion (DLI) increased HLA-DR post-transplant and augmented GVL, and efficacy seen in the four patients (NCT04628338) [24].